Santhera Pharmaceuticals Duchenne Drug Development Update
March 22nd, 2021
Santhera Pharmaceuticals Duchenne Drug Development Update – Vamorolone in Duchenne muscular dystrophy
Parent Project Muscular Dystrophy and Santhera Pharmaceuticals are holding a webinar on Wednesday, March 24 at 1 PM (USA Eastern Daylight Time – 5pm Irish time). Santhera will provide an update to the community about the investigational therapy vamorolone, the use of steroids to treat Duchenne muscular dystrophy, clinical trials for vamorolone, and development timelines.
Please submit questions in advance to firstname.lastname@example.org (subject line: Santhera Webinar) by Monday, March 22 at 12 PM EDT.